shortage-alerts/shortages-vyvanse-lisdexamfetamine-dimesilate-capsules
As of October 2024, there is still an Adderall shortage in the USA Lisdexamfetamine, Guanfacine and Atomoxetine. Adderall is made up of
by YA Heo 2024 Cited by 41Oral lisdexamfetamine dimesylate (Vyvanse; lisdexamfetamine), a prodrug of dextroamfetamine, is currently the only drug to be approved in the USA for the
The FDA approved lisdexamfetamine, a generic version of Vyvanse, in August 2024, but it quickly fell into shortage by early 2024. Despite the shortage
Mylan (Viatris) has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Rhodes has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Solco has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Sun Pharma has lisdexamfetamine capsules on shortage due to
shortages as of late 2024. The medications facing shortages include methylphenidate, lisdexamfetamine, guanfacine, and atomoxetine, with
The FDA approved lisdexamfetamine, a generic version of Vyvanse, in August 2024, but it quickly fell into shortage by early 2024. Despite the shortage
The FDA approved lisdexamfetamine, a Vyvanse generic, in August 2024. Lisdexamfetamine, along with many other ADHD medications, is currently also in shortage.
The FDA approved lisdexamfetamine, a generic version of Vyvanse, in August 2024, but it quickly fell into shortage by early 2024. Despite the shortage
Comments